Related Experiment Videos
[Progressive multifocal leukoencephalopathy (PML) in AIDS: morphological and topographical characteristics]
K Kuchelmeister1, F Gullotta, M Bergmann
1Institut für Neuropathologie, Universität Münster.
Summary
This study examined 15 autopsy cases of progressive multifocal leukoencephalopathy (PML) in patients with acquired immunodeficiency syndrome (AIDS). Findings revealed large, necrotic PML lesions, often with brainstem and cerebellum involvement, potentially linked to toxic factors.
Area of Science:
- Neuropathology
- Infectious Diseases
- Acquired Immunodeficiency Syndrome (AIDS)
Context:
- Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic infection affecting the central nervous system.
- In the context of acquired immunodeficiency syndrome (AIDS), PML can present with unique and severe neuropathological features.
- Understanding these features is crucial for diagnosing and managing neurological complications in AIDS patients.
Purpose:
- To describe the neuropathological findings in a series of autopsy cases of PML in patients with AIDS.
- To identify frequent and characteristic lesions, including size, necrosis, inflammatory infiltrates, and topographical distribution.
- To explore potential contributing factors, such as additional toxic influences, to the observed PML characteristics.
Summary:
- Autopsy of 15 AIDS patients revealed frequent large, confluent PML lesions with prominent necrosis (10/15) and perivascular mononuclear infiltrates (6/15).
- Cerebellar and/or brainstem involvement occurred in 9/15 cases, with one case showing exclusive involvement of these regions.
- Co-occurrence of HIV-encephalopathy with multinucleated macrophages was noted in 7/15 cases, suggesting potential interplay of pathologies.
Impact:
- Highlights the severe and distinct neuropathological manifestations of PML in the setting of AIDS.
- Suggests that additional toxic factors may contribute to the observed severity and location of PML lesions in AIDS.
- Provides valuable insights for neuropathologists and clinicians dealing with neurological opportunistic infections in immunocompromised individuals.